Published in Cancer Weekly, May 10th, 2005
TORI is devoted to evaluating agents for cancer treatment. Clarient, formerly known as ChromaVision Medical Systems, is a provider of automated cell-imaging systems and advanced oncology laboratory services.
"We are delighted with the opportunity to offer our lab services expertise and diagnostic technologies to support TORI in breast cancer clinical trials," said Kenneth D. Bauer,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.